Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15133881 | Publishing Date : 28-Jan-2020 | No. of pages : 93
Detailed TOC of Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cutaneous Fibrosis Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Cutaneous Fibrosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Corticosteroids
1.4.3 Anti-Fibrotic Drugs
1.4.4 Immunoglobulins
1.5 Market by Application
1.5.1 Global Cutaneous Fibrosis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Cutaneous Fibrosis Drugs Market Perspective (2015-2026)
2.2 Cutaneous Fibrosis Drugs Growth Trends by Regions
2.2.1 Cutaneous Fibrosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cutaneous Fibrosis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Cutaneous Fibrosis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cutaneous Fibrosis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Cutaneous Fibrosis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Fibrosis Drugs Players by Market Size
3.1.1 Global Top Cutaneous Fibrosis Drugs Players by Revenue (2015-2020)
3.1.2 Global Cutaneous Fibrosis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Cutaneous Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cutaneous Fibrosis Drugs Market Concentration Ratio
3.2.1 Global Cutaneous Fibrosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cutaneous Fibrosis Drugs Revenue in 2019
3.3 Cutaneous Fibrosis Drugs Key Players Head office and Area Served
3.4 Key Players Cutaneous Fibrosis Drugs Product Solution and Service
3.5 Date of Enter into Cutaneous Fibrosis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cutaneous Fibrosis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Cutaneous Fibrosis Drugs Forecasted Market Size by Type (2021-2026)
5 Cutaneous Fibrosis Drugs Breakdown Data by Application (2015-2026)
5.1 Global Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
5.2 Global Cutaneous Fibrosis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cutaneous Fibrosis Drugs Market Size (2015-2020)
6.2 Cutaneous Fibrosis Drugs Key Players in North America (2019-2020)
6.3 North America Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
6.4 North America Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cutaneous Fibrosis Drugs Market Size (2015-2020)
7.2 Cutaneous Fibrosis Drugs Key Players in Europe (2019-2020)
7.3 Europe Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
7.4 Europe Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Cutaneous Fibrosis Drugs Market Size (2015-2020)
8.2 Cutaneous Fibrosis Drugs Key Players in China (2019-2020)
8.3 China Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
8.4 China Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cutaneous Fibrosis Drugs Market Size (2015-2020)
9.2 Cutaneous Fibrosis Drugs Key Players in Japan (2019-2020)
9.3 Japan Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
9.4 Japan Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cutaneous Fibrosis Drugs Market Size (2015-2020)
10.2 Cutaneous Fibrosis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Cutaneous Fibrosis Drugs Market Size (2015-2020)
11.2 Cutaneous Fibrosis Drugs Key Players in India (2019-2020)
11.3 India Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
11.4 India Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cutaneous Fibrosis Drugs Market Size (2015-2020)
12.2 Cutaneous Fibrosis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Cutaneous Fibrosis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Cutaneous Fibrosis Drugs Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Cutaneous Fibrosis Drugs Introduction
13.1.4 Pfizer Revenue in Cutaneous Fibrosis Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Cutaneous Fibrosis Drugs Introduction
13.2.4 Novartis Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Cutaneous Fibrosis Drugs Introduction
13.3.4 Sanofi Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Cutaneous Fibrosis Drugs Introduction
13.4.4 Merck Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Cutaneous Fibrosis Drugs Introduction
13.5.4 Roche Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.5.5 Roche Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.6.3 GlaxoSmithKline Cutaneous Fibrosis Drugs Introduction
13.6.4 GlaxoSmithKline Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Bayer
13.7.1 Bayer Company Details
13.7.2 Bayer Business Overview and Its Total Revenue
13.7.3 Bayer Cutaneous Fibrosis Drugs Introduction
13.7.4 Bayer Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.7.5 Bayer Recent Development
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Details
13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.8.3 Boehringer Ingelheim Cutaneous Fibrosis Drugs Introduction
13.8.4 Boehringer Ingelheim Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.8.5 Boehringer Ingelheim Recent Development
13.9 Horizon Pharma
13.9.1 Horizon Pharma Company Details
13.9.2 Horizon Pharma Business Overview and Its Total Revenue
13.9.3 Horizon Pharma Cutaneous Fibrosis Drugs Introduction
13.9.4 Horizon Pharma Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.9.5 Horizon Pharma Recent Development
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Details
13.10.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.10.3 Bristol-Myers Squibb Cutaneous Fibrosis Drugs Introduction
13.10.4 Bristol-Myers Squibb Revenue in Cutaneous Fibrosis Drugs Business (2015-2020)
13.10.5 Bristol-Myers Squibb Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Cutaneous Fibrosis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Cutaneous Fibrosis Drugs Revenue
Table 3. Ranking of Global Top Cutaneous Fibrosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cutaneous Fibrosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Anti-Fibrotic Drugs
Table 7. Key Players of Immunoglobulins
Table 8. Global Cutaneous Fibrosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cutaneous Fibrosis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cutaneous Fibrosis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cutaneous Fibrosis Drugs Market Share by Regions (2015-2020)
Table 12. Global Cutaneous Fibrosis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cutaneous Fibrosis Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cutaneous Fibrosis Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Cutaneous Fibrosis Drugs Players
Table 19. Global Cutaneous Fibrosis Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cutaneous Fibrosis Drugs Market Share by Players (2015-2020)
Table 21. Global Top Cutaneous Fibrosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Fibrosis Drugs as of 2019)
Table 22. Global Cutaneous Fibrosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cutaneous Fibrosis Drugs Product Solution and Service
Table 25. Date of Enter into Cutaneous Fibrosis Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cutaneous Fibrosis Drugs Market Size Share by Type (2015-2020)
Table 29. Global Cutaneous Fibrosis Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Cutaneous Fibrosis Drugs Market Size Share by Application (2015-2020)
Table 31. Global Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cutaneous Fibrosis Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 35. North America Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 37. North America Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 41. Europe Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 43. Europe Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 47. China Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. China Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 49. China Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 53. Japan Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 55. Japan Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 59. Southeast Asia Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 61. Southeast Asia Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 65. India Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. India Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 67. India Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cutaneous Fibrosis Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cutaneous Fibrosis Drugs Market Share (2019-2020)
Table 71. Central & South America Cutaneous Fibrosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cutaneous Fibrosis Drugs Market Share by Type (2015-2020)
Table 73. Central & South America Cutaneous Fibrosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cutaneous Fibrosis Drugs Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Product
Table 98. Roche Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 99. Roche Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Business Overview
Table 107. Bayer Product
Table 108. Bayer Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 109. Bayer Recent Development
Table 110. Boehringer Ingelheim Business Overview
Table 111. Boehringer Ingelheim Product
Table 112. Boehringer Ingelheim Company Details
Table 113. Boehringer Ingelheim Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 114. Boehringer Ingelheim Recent Development
Table 115. Horizon Pharma Company Details
Table 116. Horizon Pharma Business Overview
Table 117. Horizon Pharma Product
Table 118. Horizon Pharma Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 119. Horizon Pharma Recent Development
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Product
Table 123. Bristol-Myers Squibb Revenue in Cutaneous Fibrosis Drugs Business (2015-2020) (Million US$)
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Fibrosis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Corticosteroids Features
Figure 3. Anti-Fibrotic Drugs Features
Figure 4. Immunoglobulins Features
Figure 5. Global Cutaneous Fibrosis Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Cutaneous Fibrosis Drugs Report Years Considered
Figure 10. Global Cutaneous Fibrosis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cutaneous Fibrosis Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Cutaneous Fibrosis Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cutaneous Fibrosis Drugs Market Share by Players in 2019
Figure 15. Global Top Cutaneous Fibrosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Fibrosis Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cutaneous Fibrosis Drugs Revenue in 2019
Figure 17. North America Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cutaneous Fibrosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GlaxoSmithKline Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bayer Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 38. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Boehringer Ingelheim Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 40. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Horizon Pharma Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 42. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Keyplayers in Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2020-2026
PfizerNovartis
Sanofi
Merck
Roche
GlaxoSmithKline
Bayer
Boehringer Ingelheim
Horizon Pharma
Bristol-Myers Squibb